David A. Sheridan

Plymouth, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Medical therapy of MASLD - consequences of the paradigm shift from histology to non-invasive tests.

Medical therapy of MASLD - consequences of the paradigm shift from histology to non-invasive tests.

Journal: JHEP reports : innovation in hepatology

Published: February 23, 2026

Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?

Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?

Journal: Frontiers in immunology

Published: July 07, 2024

Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study.

Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study.

Journal: BMJ open

Published: January 18, 2024

Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD.

Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD.

Journal: Diabetes research and clinical practice

Published: January 18, 2024

Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.

Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.

Journal: Alimentary pharmacology & therapeutics

Published: July 28, 2023

National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022.

National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022.

Journal: JHEP reports : innovation in hepatology

Published: April 12, 2023

Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis.

Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis.

Journal: Scientific reports

Published: October 18, 2021

Patients with moderate to severe COVID-19 have an impaired cytokine response with an exhausted and senescent immune phenotype.

Patients with moderate to severe COVID-19 have an impaired cytokine response with an exhausted and senescent immune phenotype.

Journal: Immunobiology

Published: October 10, 2021

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.

Journal: Journal of hepatology

Published: July 27, 2021

Letter: long-term abdominal drains in refractory ascites-evolving concept of palliative care in decompensated cirrhosis. Authors' reply.

Letter: long-term abdominal drains in refractory ascites-evolving concept of palliative care in decompensated cirrhosis. Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: October 05, 2020

Editorial: palliative long-term abdominal drains in refractory ascites-a step in the right direction, but not the complete solution. Authors' reply.

Editorial: palliative long-term abdominal drains in refractory ascites-a step in the right direction, but not the complete solution. Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: September 05, 2020

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.

Journal: The lancet. Gastroenterology & hepatology

Published: July 28, 2020

Showing 1-12 of 39

Last Updated: 09/26/2026